BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36833593)

  • 1. Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients.
    Castelletti S; Orini M; Vischer AS; McKenna WJ; Lambiase PD; Pantazis A; Crotti L
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
    Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
    J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
    Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
    Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
    Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of heart rate variability with arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Battipaglia I; Scalone G; Macchione A; Pinnacchio G; Laurito M; Milo M; Pelargonio G; Bencardino G; Bellocci F; Pieroni M; Lanza GA; Crea F
    Circ J; 2012; 76(3):618-23. PubMed ID: 22260941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
    Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
    Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2022 Aug; 43(32):e1-e9. PubMed ID: 35441664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
    Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.